These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 664867)

  • 1. [Method of obtaining antisera with a high titer of antibodies to the causative agent of cutaneous leishmaniasis in rabbits].
    Dobrzhanskaia RS
    Vestn Dermatol Venerol; 1978 May; (5):80-4. PubMed ID: 664867
    [No Abstract]   [Full Text] [Related]  

  • 2. Sub-clinical infection as an effective protocol for obtaining anti-Leishmania chagasi amastigote antibodies of different animal species.
    Fróes AM; dos Santos CV; Penha-Filho ML; Teixeira MC; Correa Silva TM; Oliveira GG; dos Santos WL; Pontes-de-Carvalho LC; Alcântara-Neves NM
    Vet Immunol Immunopathol; 2004 Jun; 99(3-4):135-41. PubMed ID: 15135980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intralymphnode injection of human monocyte macrophage colony stimulating factor (CSF-1) as a method of obtaining high titer anti-CSF-1 antibodies.
    Praloran V; Martin-Thouvenin V; Berrada L; Moreau A; Lanotte M
    Eur Cytokine Netw; 1990; 1(3):177-83. PubMed ID: 1717026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A suspected new species of Leishmania, the causative agent of visceral leishmaniasis in a Thai patient.
    Sukmee T; Siripattanapipong S; Mungthin M; Worapong J; Rangsin R; Samung Y; Kongkaew W; Bumrungsana K; Chanachai K; Apiwathanasorn C; Rujirojindakul P; Wattanasri S; Ungchusak K; Leelayoova S
    Int J Parasitol; 2008 May; 38(6):617-22. PubMed ID: 18262531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental cutaneous leishmaniasis. IV. Selective suppression of cell-mediated immunity during the response of guinea-pigs to infection with Leishmania enriettii.
    Bryceson AD; Bray RS; Dumonde DC
    Clin Exp Immunol; 1974 Feb; 16(2):189-202. PubMed ID: 4619877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Feline leishmaniasis: what's the epidemiological role of the cat?].
    Mancianti F
    Parassitologia; 2004 Jun; 46(1-2):203-6. PubMed ID: 15305717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leishmania transmission-blocking vaccines: a review.
    Tonui WK
    East Afr Med J; 1999 Feb; 76(2):93-6. PubMed ID: 10442130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating antibodies in cutaneous leishmaniasis: their detection by immunofluorescence.
    Matossian RM; Kurban AK; Malak JA
    Trans R Soc Trop Med Hyg; 1975; 69(5-6):450-2. PubMed ID: 779154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leishmanial serotypes as distinguished by the gel diffusion of factors excreted in vitro and in vivo.
    Schnur LF; Zuckerman A; Greenblatt CL
    Isr J Med Sci; 1972 Jul; 8(7):932-42. PubMed ID: 4115563
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the immunology and serology of leishmaniasis: VI. Searh for antigenic variation in single strains of Leishmania spp.
    Bray RS
    Trans R Soc Trop Med Hyg; 1969; 63(3):378-82. PubMed ID: 5795161
    [No Abstract]   [Full Text] [Related]  

  • 11. [Leishmaniasis: principles of the immune response and function of nitric oxide].
    Bogdan C
    Berl Munch Tierarztl Wochenschr; 1998; 111(11-12):409-14. PubMed ID: 9880934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization with the cysteine proteinase Ldccys1 gene from Leishmania (Leishmania) chagasi and the recombinant Ldccys1 protein elicits protective immune responses in a murine model of visceral leishmaniasis.
    Ferreira JH; Gentil LG; Dias SS; Fedeli CE; Katz S; Barbiéri CL
    Vaccine; 2008 Jan; 26(5):677-85. PubMed ID: 18160187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of the dose of Leishmania tropica major culture on antibody formation in mice with cutaneous leishmaniasis].
    Dobrzhanskaia RS
    Med Parazitol (Mosk); 1977; 46(4):454-61. PubMed ID: 927378
    [No Abstract]   [Full Text] [Related]  

  • 14. Characterization of a membrane antigen of Leishmania amazonensis that stimulates human immune responses.
    Burns JM; Scott JM; Carvalho EM; Russo DM; March CJ; Van Ness KP; Reed SG
    J Immunol; 1991 Jan; 146(2):742-8. PubMed ID: 1824776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of methods for obtaining high-titer antispirochete sera].
    Lozeva T; Ivanov P
    Vet Med Nauki; 1975; 12(4):39-42. PubMed ID: 1216681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leishmania: amastigotes synthesize conserved secretory acid phosphatases during human infection.
    Ellis SL; Shakarian AM; Dwyer DM
    Exp Parasitol; 1998 Jun; 89(2):161-8. PubMed ID: 9635439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preparation and purification of the antibody against ribonuclease inhibitor].
    Shu XH; Li CG; Zhang HT; Chen JX; Tian YX; Yu LH; Cui XY
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Sep; 20(5):572-4. PubMed ID: 15367350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the macrophage in cutaneous leishmaniasis.
    Farah FS; Samra SA; Nuwayri-Salti N
    Immunology; 1975 Oct; 29(4):755-64. PubMed ID: 1184120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exacerbation of murine cutaneous leishmaniasis by adoptive transfer of parasite-specific helper T cell populations capable of mediating Leishmania major-specific delayed-type hypersensitivity.
    Titus RG; Lima GC; Engers HD; Louis JA
    J Immunol; 1984 Sep; 133(3):1594-600. PubMed ID: 6205088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Specific immunization in cutaneous leishmaniasis--a review].
    Barral-Netto M; Barral A
    Mem Inst Oswaldo Cruz; 1987; 82(2):293-302. PubMed ID: 3333535
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.